GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 114 filers reported holding GOSSAMER BIO INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,438,424 | +30.8% | 6,530,288 | +88.5% | 0.52% | +53.3% |
| Q2 2023 | $4,158,182 | -4.8% | 3,465,152 | 0.0% | 0.34% | -7.2% |
| Q1 2023 | $4,366,092 | +5229.8% | 3,465,152 | +9079.2% | 0.36% | +5071.4% |
| Q4 2022 | $81,918 | -99.6% | 37,750 | -97.8% | 0.01% | -99.6% |
| Q3 2022 | $20,973,000 | +43.1% | 1,750,651 | 0.0% | 1.66% | +29.8% |
| Q2 2022 | $14,653,000 | -3.9% | 1,750,651 | -0.3% | 1.28% | +8.3% |
| Q1 2022 | $15,249,000 | -24.0% | 1,756,757 | -0.9% | 1.18% | -8.0% |
| Q4 2021 | $20,052,000 | -10.0% | 1,772,950 | 0.0% | 1.28% | -4.8% |
| Q3 2021 | $22,286,000 | +54.8% | 1,772,950 | 0.0% | 1.34% | +69.6% |
| Q2 2021 | $14,396,000 | -12.2% | 1,772,950 | 0.0% | 0.79% | -15.1% |
| Q1 2021 | $16,400,000 | -2.5% | 1,772,950 | +1.9% | 0.93% | +5.9% |
| Q4 2020 | $16,817,000 | +25.8% | 1,739,050 | +61.4% | 0.88% | +20.2% |
| Q3 2020 | $13,368,000 | +403.5% | 1,077,200 | +427.5% | 0.73% | +361.6% |
| Q2 2020 | $2,655,000 | – | 204,214 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |